GlassScriptPhysician profile
Jesse Dovich
NPI 1821188996
$7,280.53
in general payments reported to CMS, 2019-2025
18 companies · $555 in 2025
The $555 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,443 · 2020: $1,810 · 2021: $98.50 · 2022: $232 · 2023: $26.16 · 2024: $1,116 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $600 · Grant: $450 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $600.00 |
| Grant | $449.55 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $3,374.71 | 2019-2025 | Photrexa, Travoprost Intraocular Implant - Idose, Istent Infinite |
| Eyevance Pharmaceuticals LLC | $1,483.43 | 2019-2020 | |
| Abbvie INC. | $485.72 | 2023-2025 | Lumigan, Vuity, Alphagan P |
| Ivantis, INC | $278.66 | 2019 | |
| Rxsight INC | $254.59 | 2021-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $236.36 | 2019-2022 | |
| Tearlab Corp | $188.72 | 2024 | Scoutpro Osmolarity System |
| Kala Pharmaceuticals, INC. | $185.23 | 2019-2020 | |
| Alcon Vision LLC | $185.06 | 2019-2024 | Clareon |
| New World Medical,INC. | $169.51 | 2019-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Aerie Pharmaceuticals, INC. | $151.94 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $74.24 | 2022 | |
| Sight Sciences, INC. | $61.20 | 2019 | |
| Carl Zeiss Meditec, INC. | $60.00 | 2022 | |
| Glaxosmithkline, LLC. | $32.51 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.92 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.84 | 2019 | |
| Beaver-Visitec International, INC. | $12.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Dovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.